
Sign up to save your podcasts
Or


Dr. Ozlem Tureci and Dr. Ugur Sahin, the co-founders of BioNTech, are behind the first coronavirus vaccine to be approved in the West. Starting next week, the “Pfizer vaccine” will be available in Britain.
While Pfizer is financing and distributing the vaccine, the science behind it was actually spearheaded by the couple’s lesser-known company. When Drs. Tureci and Sahin, along with their BioNTech team, embarked on this mission, the record for the fastest vaccine creation was four years. They did it in less than one.
BioNTech started working on a vaccine in January. By early November, the company shared the results of its Phase 3 trials: over 90 percent efficacy. The announcement was made days after the presidential election was called for Joe Biden, and Donald Trump claimed the timing was politically motivated.
In this episode of “Sway,” the couple dismiss that accusation and speak instead to the science. “Clinical trials are highly regulated,” Dr. Tureci says. “And this is something which you cannot really delay or stop or expedite.”
You can find transcripts (posted midday) and more information for all episodes at nytimes.com/sway, and you can find Kara on Twitter @karaswisher.
Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify.
By New York Times Opinion3.6
7676 ratings
Dr. Ozlem Tureci and Dr. Ugur Sahin, the co-founders of BioNTech, are behind the first coronavirus vaccine to be approved in the West. Starting next week, the “Pfizer vaccine” will be available in Britain.
While Pfizer is financing and distributing the vaccine, the science behind it was actually spearheaded by the couple’s lesser-known company. When Drs. Tureci and Sahin, along with their BioNTech team, embarked on this mission, the record for the fastest vaccine creation was four years. They did it in less than one.
BioNTech started working on a vaccine in January. By early November, the company shared the results of its Phase 3 trials: over 90 percent efficacy. The announcement was made days after the presidential election was called for Joe Biden, and Donald Trump claimed the timing was politically motivated.
In this episode of “Sway,” the couple dismiss that accusation and speak instead to the science. “Clinical trials are highly regulated,” Dr. Tureci says. “And this is something which you cannot really delay or stop or expedite.”
You can find transcripts (posted midday) and more information for all episodes at nytimes.com/sway, and you can find Kara on Twitter @karaswisher.
Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify.

8,880 Listeners

38,430 Listeners

6,881 Listeners

3,917 Listeners

4,113 Listeners

1,491 Listeners

9,724 Listeners

2,066 Listeners

144 Listeners

113,121 Listeners

1,522 Listeners

12,630 Listeners

309 Listeners

7,244 Listeners

466 Listeners

51 Listeners

2,349 Listeners

380 Listeners

6,679 Listeners

5,576 Listeners

16,525 Listeners

1,500 Listeners

11,013 Listeners

1,600 Listeners

3,538 Listeners

747 Listeners

13 Listeners

632 Listeners

27 Listeners

91 Listeners

0 Listeners